BioSpace News Archive

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that it will host a two-part virtual miniseries in September focused on key topics related to omidubicel , an advanced cell therapy in Phase 3 clinical development as a potentially life-saving treatment option for patients in need of a bone marrow transplant. The webcasts will take

Impulse Dynamics, Inc., a company dedicated to improving the lives of people with heart failure, today announced that a proposed rule by the Centers for Medicare and Medicaid Services (CMS) could further streamline coverage of its innovative CCM ® therapy delivered by the Optimizer ® system. The proposed Medicare

Seattle Genetics to Present at the Morgan Stanley 18 th Annual Global Healthcare Conference

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host its fourth annual virtual R&D Day for analysts and investors at 8:00 a.m. ET on Thursday, September 17. Moderna’s R&D Day will include presentations from Stéphane Bancel, Chief Executive Officer,

Bio-Thera Solutions (688177.SS), a commercial-stage biopharmaceutical company, today announced that dosing has begun in a Phase I clinical study to compare the pharmacokinetics and safety of BAT2206, a proposed biosimilar of Stelara® (ustekinumab), to US-sourced and EU-sourced reference product in normal he

inDemic provides curated research and science-based analyses. Register at no cost to use the system and receive alerts at www.indemic.org. [03-September-2020] HOUSTON , Sept. 3, 2020 /PRNewswire/ -- inDemic announces the launch of its COVID-19 knowledge management system. inDemic is a non-profit organization that provides information and synthesis related to

Castlight Health, Inc. (NYSE: CSLT) today announced that on September 1 st , 2020, Castlight was notified by the New York Stock Exchange (“NYSE”) that it has regained compliance with the NYSE’s continued listing standards.

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will participate in three upcoming virtual investor conferences. Wells Fargo’s 2020 Healthcare Conference is scheduled for September 9-10, 2020. Zymeworks is presenting on Wednesday, September 9, 2020 at 11:20 a.m. ET. Citi’s 15 th Annual BioPharma

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company update at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020. H.C. Wainwright Annual Global Investment Conference Tuesday, Sep

Gold standard clinical practice guidelines in oncology translated for greater global accessibility; free online at NCCN.org/global.